Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.
Nell, V. P. K. 1; Machold, K. P. 1; Eberl, G. 2; Stamm, T. A. 1; Uffmann, M. 3; Smolen, J. S. 1,2
43(7):906-914, July 2004.
(Format: HTML, PDF)